Around the IP Blogs! By Ieva Giedrimaite on Thursday, July 05, 2018 Alice v CLS Bank counterfeits Patent damages Proposal for a directive on copyright in the Digital Single Market Strategy SPCs Swiss claims trade marks and public policy +
Never Too Late: If you missed the IPKat last week! By Tian Lu on Wednesday, November 02, 2016 Copyright in buildings and artwork in public places non-compete clauses pfizer Pregabalin procedural fairness Swiss claims the penalties regulation Tian Lu trade mark judges unlicensed content +
Court of Appeal on Pregabalin - Pfizer still in pain, but Swiss claims re-interpreted again By Darren Smyth on Monday, October 24, 2016 actavis mylan pfizer Pregabalin Second medical use Swiss claims Warner-Lambert +
Fordham 2016: Will purposive construction of Swiss-type claims save second-medical use patents? By Annsley Merelle Ward on Tuesday, April 05, 2016 AmeriKat cost of medicines EPC 2000 event report Fordham 2016 incentivization patent enforcement Second medical use skinny label Swiss claims +
Friday Miscellany By Darren Smyth on Friday, December 04, 2015 diversity indirect infringement Miscellany Nagoya Protocol renewal fees Swiss claims unitary patent +
A novel becomes a saga - Actavis v Lilly set to go on and on By Darren Smyth on Friday, June 26, 2015 actavis declaration of non-infringement direct infringement eli lilly Improver questions indirect infringement patent prosecution history remittal Swiss claims +
When things go wrong: inherited claim formats, unforeseen consequences and using IPR to manipulate stock prices By Suleman Ali on Sunday, May 31, 2015 AIA appeal IPR patent reform Swiss claims unintended consequence +
Warner-Lambert v Actavis Mark 4: harmony between parties in ‘lyrical’ patent dispute By Darren Smyth on Tuesday, March 03, 2015 form of order infringement interim injunction prescribing guidelines Second medical use skinny label Swiss claims +